Skip to content

AVADEL PHARMACEUTICALS PLC: filings

Every AVADEL PHARMACEUTICALS PLC annual and quarterly report in the SEC record with the published financial measures it tagged, 45 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-11-04fiscal Q3 2025441280001012477-25-000031
10-Q2025-08-07fiscal Q2 2025441240001012477-25-000024
10-Q2025-05-07fiscal Q1 202543900001012477-25-000016
10-K2025-03-03fiscal FY 2024501300001012477-25-000010
10-Q2024-11-12fiscal Q3 2024421240001012477-24-000021
10-Q2024-08-08fiscal Q2 2024421200001012477-24-000017
10-Q2024-05-08fiscal Q1 202443900001012477-24-000012
10-K2024-02-29fiscal FY 2023501300001012477-24-000008
10-Q2023-11-08fiscal Q3 2023441260001012477-23-000023
10-Q2023-08-09fiscal Q2 2023431200001012477-23-000018
10-Q2023-05-04fiscal Q1 202338800001012477-23-000012
10-K2023-03-29fiscal FY 202246930001012477-23-000009
10-Q2022-11-09fiscal Q3 2022401140001012477-22-000014
10-Q2022-08-09fiscal Q2 2022391080001012477-22-000010
10-Q2022-05-09fiscal Q1 202239820001012477-22-000007
10-K2022-03-16fiscal FY 2021491290001012477-22-000004
10-Q2021-11-08fiscal Q3 2021431240001012477-21-000014
10-Q2021-08-09fiscal Q2 2021431200001012477-21-000011
10-Q2021-05-10fiscal Q1 202143900001012477-21-000008
10-K2021-03-09fiscal FY 2020511320001012477-21-000004
10-Q2020-11-09fiscal Q3 2020461300001012477-20-000017
10-Q2020-08-10fiscal Q2 2020451240001012477-20-000013
10-Q2020-05-11fiscal Q1 202046960001012477-20-000009
10-K2020-03-16fiscal FY 2019521320001012477-20-000007
10-Q2019-11-12fiscal Q3 2019491340001012477-19-000012
10-Q2019-08-09fiscal Q2 2019491300001012477-19-000008
10-Q2019-05-08fiscal Q1 201948970001012477-19-000005
10-K2019-03-15fiscal FY 2018501300001012477-19-000002
10-Q2018-11-05fiscal Q3 2018461200001012477-18-000033
10-Q2018-08-07fiscal Q2 2018461220001012477-18-000022
10-Q2018-05-04fiscal Q1 201842860001012477-18-000015
10-K2018-03-16fiscal FY 2017471210001012477-18-000008
10-Q2017-11-09fiscal Q3 2017411080001012477-17-000051
10-Q2017-08-09fiscal Q2 2017411080001012477-17-000046
10-Q2017-05-10fiscal Q1 201740820001012477-17-000033
10-K2017-03-28fiscal FY 2016451150001012477-17-000021
10-Q2016-11-14fiscal Q3 2016391020001628280-16-021308
10-Q2016-08-15fiscal Q2 2016391030001144204-16-118890
10-Q2016-05-10fiscal Q1 201639840001144204-16-100499
10-K2016-03-15fiscal FY 2015451190001144204-16-088149
20-F2015-10-01fiscal FY 2014451130001144204-15-057724
20-F2015-04-30fiscal FY 2014451130001144204-15-026535
20-F/A2014-04-30fiscal FY 2013441140001144204-14-026504
20-F2013-04-30fiscal FY 2012451140001144204-13-025123
20-F2012-04-27fiscal FY 201135930001144204-12-024442

Inspect the source

Entity
AVADEL PHARMACEUTICALS PLC / CIK 0001012477
Captured
2026-09-21T17:17:59.655Z
SEC response SHA-256
2657776e70a723d06828aae0240a4344524424707ea355b9c13371a1623553a0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001012477.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))